Colterol is a short-acting β2-adrenoreceptor agonist. Bitolterol, a prodrug for colterol, is used in the management of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD).
Patents
RocheAktiengesellschaft F Hoffmann, CH263801 (1949-09-15 to Hoffmann La Roche). National Research Council CanadaYasuo Konishi, Joanne Magoon, Suwatchai Jarussophon, WO2008092257 (2008 to National Research Council Of Canada). Location in patent: Page column 17.
References